CN104136033A - 抗酸片剂 - Google Patents

抗酸片剂 Download PDF

Info

Publication number
CN104136033A
CN104136033A CN201380010222.5A CN201380010222A CN104136033A CN 104136033 A CN104136033 A CN 104136033A CN 201380010222 A CN201380010222 A CN 201380010222A CN 104136033 A CN104136033 A CN 104136033A
Authority
CN
China
Prior art keywords
tablet
calcium carbonate
weight
tablets
breath
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380010222.5A
Other languages
English (en)
Chinese (zh)
Inventor
M.S.米拉拜耳
S.G.沙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of CN104136033A publication Critical patent/CN104136033A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201380010222.5A 2012-02-02 2013-01-31 抗酸片剂 Pending CN104136033A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261594055P 2012-02-02 2012-02-02
US61/594,055 2012-02-02
PCT/US2013/024078 WO2013116477A1 (en) 2012-02-02 2013-01-31 Antacid tablet

Publications (1)

Publication Number Publication Date
CN104136033A true CN104136033A (zh) 2014-11-05

Family

ID=48905820

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380010222.5A Pending CN104136033A (zh) 2012-02-02 2013-01-31 抗酸片剂

Country Status (12)

Country Link
US (1) US20140037759A1 (enExample)
EP (1) EP2809331A4 (enExample)
CN (1) CN104136033A (enExample)
AR (1) AR089857A1 (enExample)
BR (1) BR112014019155A8 (enExample)
CA (1) CA2863389A1 (enExample)
CO (1) CO7020922A2 (enExample)
HK (1) HK1201179A1 (enExample)
IN (1) IN2014DN06198A (enExample)
MX (1) MX2014009391A (enExample)
WO (1) WO2013116477A1 (enExample)
ZA (1) ZA201405354B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025222289A1 (en) * 2024-04-23 2025-10-30 Biovantek Calcium carbonate formulations and method of treatment of gastroesophageal reflux disease (gerd)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326338A (zh) * 1998-11-13 2001-12-12 尼康姆德法尔马公司 制备口服钙组合物的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
EP1596821A2 (en) * 2003-01-24 2005-11-23 The State Of Israel-Ministry Of Agriculture Synergistic compositions and methods for potentiating anti-oxidative activity
CA2514875A1 (en) * 2003-02-19 2004-09-02 Biovail Laboratories International Srl Rapid absorption selective 5-ht agonist formulations
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
WO2007134158A2 (en) * 2006-05-12 2007-11-22 Drugtech Corporation Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326338A (zh) * 1998-11-13 2001-12-12 尼康姆德法尔马公司 制备口服钙组合物的方法
US20100119621A1 (en) * 1998-11-13 2010-05-13 Nycomed Pharma As Process for preparing oral calcium compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
汉斯乌利奇•彼得厄特 主编: "《尤特奇 (聚甲基丙烯酸酯)应用技术指南》", 31 August 2009, article "附录1 度量/单位换算", pages: 1 *

Also Published As

Publication number Publication date
EP2809331A1 (en) 2014-12-10
ZA201405354B (en) 2015-11-25
IN2014DN06198A (enExample) 2015-10-23
AR089857A1 (es) 2014-09-24
CA2863389A1 (en) 2013-08-08
MX2014009391A (es) 2014-08-27
BR112014019155A2 (enExample) 2017-06-20
HK1201179A1 (en) 2015-08-28
BR112014019155A8 (pt) 2017-07-11
EP2809331A4 (en) 2015-07-15
CO7020922A2 (es) 2014-08-11
WO2013116477A1 (en) 2013-08-08
US20140037759A1 (en) 2014-02-06

Similar Documents

Publication Publication Date Title
CA2200568C (fr) Association therapeutique vitamino-calcique sous forme galenique unitaire de comprimes, son procede d'obtention et son utilisation
US6716454B2 (en) Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
RU2497503C2 (ru) Приятная на вкус твердая композиция, включающая нейтрализатор кислотности и стимулятор слюноотделения
EP0578768A1 (en) EDIBLE PHARMACEUTICAL COMPOSITIONS FOR TREATING DIGESTIVE PAIN PAIN.
ES2394456T3 (es) Composiciones farmacéuticas bucodispersables
JP2003034655A (ja) 速崩壊性固形製剤
RU2762754C2 (ru) Композиция для применения в предупреждении и/или лечении индуцированного онкологическим лечением мукозита полости рта и желудочно-кишечного тракта
WO2014209022A1 (en) Chewable tablet formulation comprising tadalafil or a pharmaceutically acceptable salt thereof
WO2006002836A1 (de) Brausezusammensetzungen von einschlafmitteln
MX2008002488A (es) Formulaciones de dosis solida que contienen farmacos para la perdida de peso.
JP6092672B2 (ja) 口腔内速崩壊性錠剤
JP2006232675A (ja) 複合型口腔内溶解用固形製剤
GB2214079A (en) Chewable, non-gritty calcium citrate tablet
CN104136033A (zh) 抗酸片剂
JP2010280645A (ja) γ−アミノ酪酸含有経口用組成物
US20180008562A1 (en) Oral Dosage Form Containing a Fast Release Exterior Coating
RU2426529C2 (ru) Орально распадающийся порошок, содержащий цилостазол и маннит
JP3193018U (ja) 消臭組成物錠剤
JP3545512B2 (ja) 生薬配合発泡錠
WO2010067151A1 (en) Quick disintegrating taste masked composition
US9844228B2 (en) Spray method and composition for reducing psychological hunger
DE60210308T2 (de) Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
RU2789054C2 (ru) Пероральная дозированная форма, содержащая наружное покрытие для быстрого высвобождения
WO2013080271A1 (ja) 鎮痛剤
JP2025023304A (ja) 固形製剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20141105

RJ01 Rejection of invention patent application after publication